BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations

BCG vaccination protects not only against tuberculosis but also against heterologous infections. This effect differs between individuals, yet the factors responsible for this variation are unknown. BCG-induced nonspecific protection is, at least partially, mediated by innate immune reprogramming (tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Vera P. Mourits, Valerie A. C. M. Koeken, L. Charlotte J. de Bree, Simone J. C. F. M. Moorlag, Wern Cui Chu, Xiaoli Xu, Helga Dijkstra, Heidi Lemmers, Leo A. B. Joosten, Yue Wang, Reinout van Crevel, Mihai G. Netea
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2020/5812743
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547148264112128
author Vera P. Mourits
Valerie A. C. M. Koeken
L. Charlotte J. de Bree
Simone J. C. F. M. Moorlag
Wern Cui Chu
Xiaoli Xu
Helga Dijkstra
Heidi Lemmers
Leo A. B. Joosten
Yue Wang
Reinout van Crevel
Mihai G. Netea
author_facet Vera P. Mourits
Valerie A. C. M. Koeken
L. Charlotte J. de Bree
Simone J. C. F. M. Moorlag
Wern Cui Chu
Xiaoli Xu
Helga Dijkstra
Heidi Lemmers
Leo A. B. Joosten
Yue Wang
Reinout van Crevel
Mihai G. Netea
author_sort Vera P. Mourits
collection DOAJ
description BCG vaccination protects not only against tuberculosis but also against heterologous infections. This effect differs between individuals, yet the factors responsible for this variation are unknown. BCG-induced nonspecific protection is, at least partially, mediated by innate immune reprogramming (trained immunity), which can be induced by the muramyl dipeptide (MDP) component of peptidoglycans. We aimed to study whether differential release of MDP in healthy individuals may explain variability of their response to BCG vaccination. Circulating MDP concentrations were increased up to three months after BCG vaccination. MDP concentrations at baseline, but not their increase postvaccination, positively correlated with the induction of trained immunity and not with mycobacteria-induced T-cell responses. Interestingly, MDP concentrations correlated with inflammatory markers in the circulation. In conclusion, circulating MDP concentrations are associated with the strength of trained immunity responses and thus influence the biological effects of BCG vaccination. This study increases our understanding about the role of MDP in BCG-induced trained immunity, which might help to optimize vaccine efficacy and explore novel applications of BCG vaccination.
format Article
id doaj-art-58896731c6ec463baa60fcef2646f1d7
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-58896731c6ec463baa60fcef2646f1d72025-02-03T06:45:48ZengWileyJournal of Immunology Research2314-88612314-71562020-01-01202010.1155/2020/58127435812743BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide ConcentrationsVera P. Mourits0Valerie A. C. M. Koeken1L. Charlotte J. de Bree2Simone J. C. F. M. Moorlag3Wern Cui Chu4Xiaoli Xu5Helga Dijkstra6Heidi Lemmers7Leo A. B. Joosten8Yue Wang9Reinout van Crevel10Mihai G. Netea11Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, 6525 Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, 6525 Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, 6525 Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, 6525 Nijmegen, NetherlandsInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research, Queenstown, 138673, SingaporeInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research, Queenstown, 138673, SingaporeDepartment of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, 6525 Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, 6525 Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, 6525 Nijmegen, NetherlandsInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research, Queenstown, 138673, SingaporeDepartment of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, 6525 Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, 6525 Nijmegen, NetherlandsBCG vaccination protects not only against tuberculosis but also against heterologous infections. This effect differs between individuals, yet the factors responsible for this variation are unknown. BCG-induced nonspecific protection is, at least partially, mediated by innate immune reprogramming (trained immunity), which can be induced by the muramyl dipeptide (MDP) component of peptidoglycans. We aimed to study whether differential release of MDP in healthy individuals may explain variability of their response to BCG vaccination. Circulating MDP concentrations were increased up to three months after BCG vaccination. MDP concentrations at baseline, but not their increase postvaccination, positively correlated with the induction of trained immunity and not with mycobacteria-induced T-cell responses. Interestingly, MDP concentrations correlated with inflammatory markers in the circulation. In conclusion, circulating MDP concentrations are associated with the strength of trained immunity responses and thus influence the biological effects of BCG vaccination. This study increases our understanding about the role of MDP in BCG-induced trained immunity, which might help to optimize vaccine efficacy and explore novel applications of BCG vaccination.http://dx.doi.org/10.1155/2020/5812743
spellingShingle Vera P. Mourits
Valerie A. C. M. Koeken
L. Charlotte J. de Bree
Simone J. C. F. M. Moorlag
Wern Cui Chu
Xiaoli Xu
Helga Dijkstra
Heidi Lemmers
Leo A. B. Joosten
Yue Wang
Reinout van Crevel
Mihai G. Netea
BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations
Journal of Immunology Research
title BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations
title_full BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations
title_fullStr BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations
title_full_unstemmed BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations
title_short BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations
title_sort bcg induced trained immunity in healthy individuals the effect of plasma muramyl dipeptide concentrations
url http://dx.doi.org/10.1155/2020/5812743
work_keys_str_mv AT verapmourits bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations
AT valerieacmkoeken bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations
AT lcharlottejdebree bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations
AT simonejcfmmoorlag bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations
AT werncuichu bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations
AT xiaolixu bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations
AT helgadijkstra bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations
AT heidilemmers bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations
AT leoabjoosten bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations
AT yuewang bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations
AT reinoutvancrevel bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations
AT mihaignetea bcginducedtrainedimmunityinhealthyindividualstheeffectofplasmamuramyldipeptideconcentrations